Treace Medical Concepts, Inc. (TMCI)
4.63
-0.18
(-3.74%)
USD |
NASDAQ |
Sep 08, 16:00
4.645
+0.02
(+0.32%)
After-Hours: 20:00
Treace Medical Concepts Enterprise Value : 329.48M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 329.48M |
| September 04, 2026 | 341.22M |
| September 03, 2026 | 345.78M |
| September 02, 2026 | 334.04M |
| September 01, 2026 | 327.52M |
| August 31, 2026 | 334.04M |
| August 28, 2026 | 330.78M |
| August 27, 2026 | 327.52M |
| August 26, 2026 | 335.35M |
| August 25, 2026 | 341.22M |
| August 24, 2026 | 312.51M |
| August 21, 2026 | 310.56M |
| August 20, 2026 | 318.38M |
| August 19, 2026 | 324.91M |
| August 18, 2026 | 317.73M |
| August 17, 2026 | 320.99M |
| August 14, 2026 | 339.91M |
| August 13, 2026 | 321.65M |
| August 12, 2026 | 337.30M |
| August 11, 2026 | 336.65M |
| August 10, 2026 | 332.08M |
| August 07, 2026 | 337.96M |
| August 06, 2026 | 313.17M |
| August 05, 2026 | 339.26M |
| August 04, 2026 | 336.65M |
| Date | Value |
|---|---|
| August 03, 2026 | 332.74M |
| July 31, 2026 | 308.60M |
| July 30, 2026 | 313.17M |
| July 29, 2026 | 290.99M |
| July 28, 2026 | 289.03M |
| July 27, 2026 | 293.60M |
| July 24, 2026 | 288.38M |
| July 23, 2026 | 291.64M |
| July 22, 2026 | 286.42M |
| July 21, 2026 | 303.38M |
| July 20, 2026 | 303.38M |
| July 17, 2026 | 307.95M |
| July 16, 2026 | 316.43M |
| July 15, 2026 | 314.47M |
| July 14, 2026 | 317.08M |
| July 13, 2026 | 326.21M |
| July 10, 2026 | 309.25M |
| July 09, 2026 | 331.43M |
| July 08, 2026 | 306.64M |
| July 07, 2026 | 315.12M |
| July 06, 2026 | 324.91M |
| July 02, 2026 | 302.08M |
| July 01, 2026 | 303.38M |
| June 30, 2026 | 287.07M |
| June 29, 2026 | 296.38M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tactile Systems Technology, Inc. | 437.81M |
| Abbott Laboratories | 210.25B |
| AngioDynamics, Inc. | 591.77M |
| Alphatec Holdings, Inc. | 1.912B |
| AtriCure, Inc. | 2.639B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.87M |
| Revenue (Quarterly) | 45.38M |
| Total Expenses (Quarterly) | 61.25M |
| EPS Diluted (Quarterly) | -0.244 |
| Gross Profit Margin (Quarterly) | 78.47% |
| Profit Margin (Quarterly) | -34.98% |
| Earnings Yield | -19.99% |
| Normalized Earnings Yield | -19.34 |